Wayne State University, Detroit, Michigan.
Wayne State University, Detroit, Michigan.
Am J Cardiol. 2020 May 15;125(10):1571-1576. doi: 10.1016/j.amjcard.2020.02.011. Epub 2020 Mar 5.
This study was undertaken to investigate whether obstructive sleep apnea (OSA) produces a survival advantage in acute coronary syndrome (ACS), and to evaluate the mechanism of any benefit, including the impact of age and other risk factors. The National Inpatient Sample was queried for all patients who were admitted for ACS during the years 2013 to 2014. The primary outcomes were all-cause in-hospital mortality and cardiogenic shock (CS). Multivariable logistic regression was used for analysis. A total of 1,080,340 patients with ACS were included, 63,255 patients had OSA. The majority of patients were males (60.3%) and of Caucasian race (75%). The mean age was 67 years (SEM: 0.1). Despite a higher burden of risk factors and older age, OSA patients had a lower risk for mortality and cardiogenic shock adjusted OR 0.68 (95%CI 0.61-0.75), p <0.001 and 0.81 (95%CI: 0.74 to 0.89), p <0.001 respectively. Age was an important effect modifier. Survival advantage and lower risk for CS arises at the age above 55 and become more apparent with increasing age. In conclusion, despite a higher CV risk profile, and older age, OSA produces a survival benefit in ACS. Age is a significant modifier of risk in OSA patients with ACS. Ischemic preconditioning might explain these results.
本研究旨在探讨阻塞性睡眠呼吸暂停(OSA)是否为急性冠状动脉综合征(ACS)患者带来生存优势,并评估其获益机制,包括年龄和其他危险因素的影响。利用 2013 年至 2014 年期间全国住院患者样本调查所有因 ACS 住院的患者。主要结局为全因院内死亡率和心源性休克(CS)。采用多变量逻辑回归进行分析。共纳入 1080340 例 ACS 患者,63255 例患者存在 OSA。大多数患者为男性(60.3%)和白种人(75%)。平均年龄为 67 岁(SEM:0.1)。尽管 OSA 患者的危险因素负担和年龄较大,但死亡率和心源性休克的调整后比值比(OR)分别为 0.68(95%CI 0.61-0.75),p<0.001 和 0.81(95%CI:0.74-0.89),p<0.001。年龄是一个重要的效应修饰因子。生存优势和 CS 风险降低出现在 55 岁以上,且随着年龄的增加而变得更加明显。结论:尽管 OSA 患者的 CV 风险状况和年龄较大,但 OSA 可使 ACS 患者获得生存获益。年龄是 ACS 合并 OSA 患者风险的重要修饰因子。缺血预处理可能解释这些结果。